May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Vascular Endothelial Growth Factor Level in Stage5 Retinopathy of Prematurity
Author Affiliations & Notes
  • H. Ozaki
    Ophthalmology, Fukuoka Univ Sch of Medicine, Jonan–ku, Japan
  • N. Umeda
    Ophthalmology, Fukuoka Univ Sch of Medicine, Jonan–ku, Japan
  • T. Shitama
    Ophthalmology, Fukuoka Univ Sch of Medicine, Jonan–ku, Japan
  • H. Hayashi
    Ophthalmology, Fukuoka Univ Sch of Medicine, Jonan–ku, Japan
  • K. Oshima
    Ophthalmology, Fukuoka Univ Sch of Medicine, Jonan–ku, Japan
  • Footnotes
    Commercial Relationships  H. Ozaki, None; N. Umeda, None; T. Shitama, None; H. Hayashi, None; K. Oshima, None.
  • Footnotes
    Support  Grant –in–aid for Scientific Research from the Ministry of Education, Science, Sports and Culture.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4128. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Ozaki, N. Umeda, T. Shitama, H. Hayashi, K. Oshima; Vascular Endothelial Growth Factor Level in Stage5 Retinopathy of Prematurity . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4128.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:Selecting a suitable timing for surgeries on stage 5 retinopathy of prematurity (ROP) is critical. Vitrectomies performed too early before the ceasing of the angiogenic activity may bring about high risks of angiogenic blood vessel–related complications. We have investigated the time course of intraocular vascular endothelial growth factor (VEGF) level, the principal angiogenesis factor, as an indicatot of ocular angiogenic activity in stage 5 ROPs and evaluate a suitable timing for surgical intervention. Methods:Vitreous fluids were obtained from 26 eyes from 23 patients with stage 5 ROP during vitrectomy at Fukuoka University Hospital from June 1997 to June 2003. VEGF concentrations in the vitreous fluids were determined by enzyme linked immunosorbent assay. Results:VEGF concentrations in vitreous samples ranged from 8138.4 to 0 pg/ml (Mean ± SD; 850.1 ± 2005.6 pg/ml). VEGF concentrations were comparitively elevated in eyes within 7 month after birth at the time of surgery (Mean ± SD; 1334.4 ± 2458.4 pg/ml) compared to those of the eyes later than 8 month after birth (Mean ± SD; 75.4 ± 130.0 pg/ml). (P < 0.05). Conclusions:A decrease in the intraocular concentration of VEGF was shown in patients after 8 months of age in stage 5 ROP. This may suggest a favorable timing for surgeries with less complications associated with milder angiogenic activity.

Keywords: retinopathy of prematurity • growth factors/growth factor receptors • neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×